Preclinical Validation of a Single-Treatment Infusion Modality That Can Eradicate Extremity Melanomas

Cancer Research- United States

doi 10.1158/0008-5472.can-15-2764

Full Text

Abstract

Available in

Date

Authors

Publisher

American Association for Cancer Research (AACR)

Related search

Noncutaneous Melanomas: A Single-Center Analysis

Dermatology
Dermatology
2015English

Nano-Pulse Stimulation Is a Physical Modality That Can Trigger Immunogenic Tumor Cell Death

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2017English

Preclinical Validation of Electrochemotherapy as an Effective Treatment for Brain Tumors

Cancer Research
Cancer ResearchOncology
2011English

Preclinical Validation of AR42, a Novel Histone Deacetylase Inhibitor, as Treatment for Vestibular Schwannomas

Laryngoscope
Otorhinolaryngology
2011English

Treatment Outcomes for Single Modality Management of Glomus Jugulare Tumors With Stereotactic Radiosurgery

Otology and Neurotology
MedicineOtorhinolaryngologySensory SystemsNeurology
2016English

Ankle Instabilities: Conservative Treatment Modality

Türk Ortopedi ve Travmatoloji Birliği Derneği Dergisi
2013English

Combined Modality Treatment of Anal Carcinoma

Oncologist
Cancer ResearchMedicineOncology
1998English

Thiamine in Diabetic Nephropathy: A Novel Treatment Modality?

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
2009English

Validation of Ultrasound Bioimaging to Predict Worm Burden and Treatment Efficacy in Preclinical Filariasis Drug Screening Models

Scientific Reports
Multidisciplinary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy